N. Gibson

RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib

S. Barry, O. Delpuech, J. Dry, 2013, PloS one.

Development of a Facile Fluorescent Assay for the Detection of 80 Mutations Within the p53 Gene

D. Hodgson, C. Foy, N. Gibson, 2002, Molecular medicine.

Novel technology and the development of pharmacogenetics within the pharmaceutical industry.

Neil Gibson, Ansar Jawaid, Ruth March, 2005, Pharmacogenomics.

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

A Jawaid, E M Brown, L R Cardon, 2008, The Pharmacogenomics Journal.

High-Throughput SNP Genotyping

M. Alpers, N. Gibson, S. Jenkins, 2002, Comparative and functional genomics.

Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites.

Eleftheria Zeggini, Guoying Liu, Anne Barton, 2004, American journal of human genetics.

The use of real-time PCR methods in DNA sequence variation analysis.

N. Gibson, Neil J Gibson, 2006, Clinica chimica acta; international journal of clinical chemistry.

Application of oligonucleotide arrays to high-content genetic analysis

N. Gibson, 2006, Expert review of molecular diagnostics.